Cover Image
市場調查報告書

全球蛋白質工程市場趨勢,機會分析,市場佔有率,預測

Global Protein Engineering Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 382911
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球蛋白質工程市場趨勢,機會分析,市場佔有率,預測 Global Protein Engineering Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日期: 2016年10月27日 內容資訊: 英文 140 Pages
簡介

本報告提供全球蛋白質工程市場相關調查,市場概要與至2022年的預測,競爭趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 技術參數
  • 市場趨勢
  • 競爭環境
  • 波特五力分析模式
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策因素

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各產品市場
  • 各技術市場
  • 各蛋白質類型市場
  • 各終端用戶市場

第5章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 企業簡介

  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • BIO-RAD LABORATORIES, INC.
  • BRUKER CORPORATION
  • SIGMA-ALDRICH CORPORATION
  • GENERAL ELECTRIC COMPANY
  • GENSCRIPTS, INC.
  • PERKINELMER, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • WATERS CORPORATION.
  • GE HEALTHCARE
  • AB SCIEX
  • NOVARTIS AG
  • GLAXOSMITHKLINE INC
  • ELI LILLY AND COMPANY

圖表

目錄
Product Code: HAD-3891116

The global protein engineering market is accounted for USD 610.3 million in 2016 to about USD 1463 million in 2022 at a CAGR of 15.7%. The major factors which are driving the market growth of protein engineering over the globe are increasing prevalence of chronic diseases and increasing preference among patients for protein based drugs over non-protein drugs. Increase in advancement of technology and increasing lifestyle diseases and rising government support for pharmaceutical infrastructure improvement and funds for R&D in this sector along with reduction in costs of drugs are also contributing for market growth of protein engineering over the globe.

Owing to increasing number of engineered protein and amino acids globally is offering a valuable opportunity for growing the demand of protein engineering globally. Although there are certain factors which are proving as a restraint for the market of protein engineering such as lack of trained professional and high price and maintenance cost of engineering instrument and tools are proving to be a major factors for limiting the growth of the market. Along with this high funds requirement for Research and development, limitations in technology and less awareness among people are some of the factors which are hampering the market growth of protein engineering.

Globally the market of protein engineering is categorized on the basis of product, on the basis of technology, based upon the protein type and based upon the end user. Based upon the product the protein engineering market is sub categorized in to reagents, instrument, services and software. Based upon the technology the protein engineering market is sub categorized into rational protein design and irrational protein design. Rational protein design is the highly adopted technology among the two. Based upon the product type the protein engineering market is sub categorized in to insulin, monoclonal, erythropoietin, colony stimulating factor, interferon, Growth hormones, coagulation factor, vaccines, and other types of protein. Monoclonal antibodies are the fastest product type in this market due to its rising adoption for therapies for cancer and other autoimmune diseases. Based on end user it is sub categorized by pharmaceutical and biotechnology companies, academic research institutes, contract research organizations. Pharmaceutical and biotechnology sector is the fastest growing sector and largest consumer for protein engineering market.

On the basis of the geography the protein engineering market is mainly segmented into North America, Latin America, Europe, APAC and the rest of the world. North America has foreseen as a dominant region owing to the rising research activities and increasing government initiatives. Europe is the second largest market of protein engineering due to the technological advancement and increasing demand of protein drugs.

The protein engineering market is dominated by some of the major key players such as are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., General Electric Company, Thermo Fisher Scientific, Inc., GlaxoSmithKline Inc , Sigma-Aldrich Corporation, GE healthcare, Bruker Corporation, Genscripts, Inc., PerkinElmer, Inc. these are the key player who dominate the world market with 50% share of global protein engineering market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP EMERGING COUNTRIES
    • 2.4.2. TOP REVENUE GENERATING SEGMENTS
    • 2.4.3. EMERGING TRENDS
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISE IN ADOPTION OF PROTEIN BASED DRUGS
    • 3.1.2. INCREASING PREVALENCE OF LIFE STYLE DISEASES
    • 3.1.3. INCREASING FUNDING FOR PROTEIN BASED ENGINEERING
    • 3.1.4. REDUCTION IN COST FOR DISCOVERY OF DRUG
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. EXPENSIVE AND HIGH MAINTENANCE AND INSTRUMENT IN PROTEIN ENGINEERING
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. PROTEIN THERAPY AS AN ALTERNATIVE TO GENE THERAPY
    • 3.3.2. SIGNIFICANT GROWTH IN EMERGING ECONOMIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. NEED FOR MANDATORY TRAINING AND QUALIFIED RESEARCHERS IN PROTEIN ENGINEERING
    • 3.4.2. HIGH PROCESS COST
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL PROTEIN ENGINEERING BY PRODUCT 2014-2022 ($ MILLION)
    • 4.1.1. GLOBAL REAGENTS MARKET 2014-2022 ($ MILLION)
    • 4.1.2. GLOBAL INSTRUMENT MARKET 2014-2022 ($ MILLION)
    • 4.1.3. GLOBAL SERVICES AND SOFTWARE MARKET 2014-2022 ($ MILLION)
  • 4.2. GLOBAL PROTEIN ENGINEERING BY TECHNOLOGY MARKET 2014-2022 ($ MILLION)
    • 4.2.1. GLOBAL RATIONAL PROTEIN DESIGN MARKET 2014-2022 ($ MILLION)
    • 4.2.2. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 2014-2022 ($ MILLION)
  • 4.3. GLOBAL PROTEIN ENGINEERING BY PROTEIN TYPE 2014-2022 ($ MILLION)
    • 4.3.1. GLOBAL INSULIN MARKET 2014-2022 ($ MILLION)
    • 4.3.2. GLOBAL MONOCLONAL ANTIBODIES MARKET 2014-2022 ($ MILLION)
    • 4.3.3. GLOBAL ERYTHROPOIETIN MARKET 2014-2022 ($ MILLION)
    • 4.3.4. GLOBAL COLONY STIMULATING FACTOR MARKET 2014-2022 ($ MILLION)
    • 4.3.5. GLOBAL INTERFERON MARKET 2014-2022 ($ MILLION)
    • 4.3.6. GLOBAL GROWTH HORMONES MARKET 2014-2022 ($ MILLION)
    • 4.3.7. GLOBAL COAGULATION FACTOR MARKET 2014-2022 ($ MILLION)
    • 4.3.8. GLOBAL VACCINES MARKET 2014-2022 ($ MILLION)
    • 4.3.9. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • 4.4. GLOBAL PROTEIN ENGINEERING BY END USER 2014-2022 ($ MILLION)
    • 4.4.1. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2014-2022 ($ MILLION)
    • 4.4.2. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET 2014-2022 ($ MILLION)
    • 4.4.3. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET 2014-2022 ($ MILLION)

5. GEOGRAPHIC ANALYSIS

  • 5.1. NORTH AMERICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (US) PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.4. SPAIN PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.3.2. CHINA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.3.4. ROAPAC PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.4.2. MENA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
    • 5.4.3. AFRICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILES

  • 6.1. AGILENT TECHNOLOGIES, INC.
  • 6.2. DANAHER CORPORATION
  • 6.3. BIO-RAD LABORATORIES, INC.
  • 6.4. BRUKER CORPORATION
  • 6.5. SIGMA-ALDRICH CORPORATION
  • 6.6. GENERAL ELECTRIC COMPANY
  • 6.7. GENSCRIPTS, INC.
  • 6.8. PERKINELMER, INC.
  • 6.9. THERMO FISHER SCIENTIFIC, INC.
  • 6.10. WATERS CORPORATION.
  • 6.11. GE HEALTHCARE
  • 6.12. AB SCIEX
  • 6.13. NOVARTIS AG
  • 6.14. GLAXOSMITHKLINE INC
  • 6.15. ELI LILLY AND COMPANY

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN ENGINEERING BY PRODUCT 2014-2022 ($ MILLION)
  • TABLE 2. GLOBAL REAGENTS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 3. GLOBAL INSTRUMENT MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 4. GLOBAL SERVICES AND SOFTWARE MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 5. GLOBAL PROTEIN ENGINEERING BY TECHNOLOGY MARKET 2014-2022 ($ MILLION)
  • TABLE 6. GLOBAL RATIONAL PROTEIN DESIGN MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 7. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 8. GLOBAL PROTEIN ENGINEERING BY PROTEIN TYPE 2014-2022 ($ MILLION)
  • TABLE 9. GLOBAL INSULIN MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 10. GLOBAL MONOCLONAL ANTIBODIES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 11. GLOBAL ERYTHROPOIETIN MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 12. GLOBAL COLONY STIMULATING FACTOR MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 13. GLOBAL INTERFERON MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 14. GLOBAL GROWTH HORMONES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 15. GLOBAL COAGULATION FACTOR MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 16. GLOBAL VACCINES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 17. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 18. GLOBAL PROTEIN ENGINEERING BY END USER 2014-2022 ($ MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 20. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY GEOGRAPHY 2014-2022 ($ MILLION)
  • TABLE 22. NORTH AMERICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • TABLE 23. EUROPE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • TABLE 24. ASIA PACIFIC PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • TABLE 25. REST OF THE WORLD PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL REAGENTS MARKET 2014-2022 ($ MILLION)
  • FIGURE 2. GLOBAL INSTRUMENT MARKET 2014-2022 ($ MILLION)
  • FIGURE 3. GLOBAL SERVICES AND SOFTWARE MARKET 2014-2022 ($ MILLION)
  • FIGURE 4. GLOBAL RATIONAL PROTEIN DESIGN MARKET 2014-2022 ($ MILLION)
  • FIGURE 5. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 2014-2022 ($ MILLION)
  • FIGURE 6. GLOBAL INSULIN MARKET 2014-2022 ($ MILLION)
  • FIGURE 7. GLOBAL MONOCLONAL ANTIBODIES MARKET 2014-2022 ($ MILLION)
  • FIGURE 8. GLOBAL ERYTHROPOIETIN MARKET 2014-2022 ($ MILLION)
  • FIGURE 9. GLOBAL COLONY STIMULATING FACTOR MARKET 2014-2022 ($ MILLION)
  • FIGURE 10. GLOBAL INTERFERON MARKET 2014-2022 ($ MILLION)
  • FIGURE 11. GLOBAL GROWTH HORMONES MARKET 2014-2022 ($ MILLION)
  • FIGURE 12. GLOBAL COAGULATION FACTOR MARKET 2014-2022 ($ MILLION)
  • FIGURE 13. GLOBAL VACCINES MARKET 2014-2022 ($ MILLION)
  • FIGURE 14. GLOBAL OTHERS MARKET 2014-2022 ($ MILLION)
  • FIGURE 15. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2014-2022 ($ MILLION)
  • FIGURE 16. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET 2014-2022 ($ MILLION)
  • FIGURE 17. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET 2014-2022 ($ MILLION)
  • FIGURE 18. NORTH AMERICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 19. UNITED STATES (US) PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 20. CANADA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 21. EUROPE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 22. UNITED KINGDOM (UK) PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 23. FRANCE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 24. GERMANY PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 25. SPAIN PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 26. ITALY PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 27. ROE PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 28. ASIA PACIFIC PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 29. INDIA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 30. CHINA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 31. JAPAN PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 32. KOREA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 33. AUSTRALIA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 34. ROAPAC PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 35. REST OF THE WORLD PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 36. LATIN AMERICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 37. MENA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
  • FIGURE 38. AFRICA PROTEIN ENGINEERING MARKET 2014-2022 ($ MILLION)
Back to Top